AIM ImmunoTech, Inc. (AIM)

0.562 +0.02 (+2.99%) USD  |  NYAM  |  Apr 16, 16:00
0.5507 -0.01 (-2.01%) After-Hours: 05:47
More

AIM ImmunoTech Return on Net Operating Assets (Annual)

Return on Net Operating Assets (Annual) Chart

View Return on Net Operating Assets (Annual) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets (Annual) Range, Past 5 Years

View Return on Net Operating Assets (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets (Annual) Benchmarks

View Return on Net Operating Assets (Annual) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Windtree Therapeutics, Inc. Upgrade
Halozyme Therapeutics, Inc. Upgrade